Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,088 | -55,262 | -35,891 | -74,810 | -120,343 |
| Depreciation Amortization | 10,384 | 7,036 | 3,611 | 37,500 | 27,717 |
| Accounts receivable | -5,053 | 747 | 5,211 | -12,806 | -8,544 |
| Accounts payable and accrued liabilities | 7,692 | -4,839 | -9,517 | 21,580 | 14,738 |
| Other Working Capital | 97,254 | 88,638 | 89,609 | -92,562 | -997 |
| Other Operating Activity | 9,088 | 12,358 | 8,888 | 21,944 | 18,385 |
| Operating Cash Flow | $37,277 | $48,678 | $61,911 | $-99,154 | $-69,044 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,779 | -2,966 | -1,597 | -3,291 | -2,540 |
| Purchase Of Investment | -145,726 | -104,488 | -70,308 | -132,361 | -112,432 |
| Sale Of Investment | 129,137 | 61,222 | 29,605 | 117,451 | 94,708 |
| Investing Cash Flow | $-20,368 | $-46,232 | $-42,300 | $-18,201 | $-20,264 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 2,972 | N/A |
| Other Financing Activity | -3 | -191 | -357 | 0 | -415 |
| Financing Cash Flow | $-3 | $-191 | $-357 | $2,972 | $-415 |
| Beginning Cash Position | 37,187 | 37,187 | 37,187 | 151,570 | 151,570 |
| End Cash Position | 54,093 | 39,442 | 56,441 | 37,187 | 61,847 |
| Net Cash Flow | $16,906 | $2,255 | $19,254 | $-114,383 | $-89,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | 37,277 | 48,678 | 61,911 | -99,154 | -69,044 |
| Capital Expenditure | -3,779 | -2,966 | -1,597 | -3,291 | -2,540 |
| Free Cash Flow | 33,498 | 45,712 | 60,314 | -102,445 | -71,584 |